Corcept Therapeutics Inc

VANGUARD GROUP INC CORT

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

9,494,822

Value ($000)

330,420

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	330,420	0.0%	9,494,822	12/31/2025
2025 Q3	11/7/2025	792,626	0.0%	9,537,071	9/30/2025
2025 Q2	8/11/2025	710,555	0.0%	9,680,592	6/30/2025
2025 Q1	5/9/2025	1,140,140	0.0%	9,981,968	3/31/2025
2024 Q4	2/11/2025	509,726	0.0%	10,115,624	12/31/2024
2024 Q3	11/13/2024	463,093	0.0%	10,006,330	9/30/2024
2024 Q2	8/13/2024	310,400	0.0%	9,553,706	6/30/2024
2024 Q1	5/10/2024	240,962	0.0%	9,565,782	3/31/2024
2023 Q4	3/11/2024	309,779	0.0%	9,537,532	12/31/2023
2023 Q3	12/18/2023	253,314	0.0%	9,297,645	9/30/2023
2023 Q2	8/14/2023	207,175	0.0%	9,311,225	6/30/2023
2023 Q1	7/14/2023	226,017	0.0%	10,434,744	3/31/2023
2022 Q4	2/10/2023	210,108	0.0%	10,345,030	12/31/2022
2022 Q3	11/14/2022	264,915	0.0%	10,332,077	9/30/2022
2022 Q2	8/12/2022	234,796	0.0%	9,873,663	6/30/2022
2022 Q1	5/13/2022	235,081	0.0%	10,438,752	3/31/2022
2021 Q4	2/14/2022	213,790	0.0%	10,797,477	12/31/2021
2021 Q3	11/12/2021	233,612	0.0%	11,870,518	9/30/2021
2021 Q2	8/13/2021	263,502	0.0%	11,977,384	6/30/2021
2021 Q1	5/14/2021	294,704	0.0%	12,387,727	3/31/2021
2020 Q4	2/12/2021	313,819	0.0%	11,996,149	12/31/2020
2020 Q3	11/16/2020	204,192	0.0%	11,731,804	9/30/2020
2020 Q2	8/14/2020	189,045	0.0%	11,239,346	6/30/2020
2020 Q1	5/15/2020	132,191	0.0%	11,117,827	3/31/2020
2019 Q4	2/14/2020	132,479	0.0%	10,948,746	12/31/2019
2014 Q2	8/11/2014	6,016	0.0%	2,148,244	6/30/2014
2014 Q1	5/13/2014	9,284	0.0%	2,129,395	3/31/2014
2013 Q4	2/12/2014	6,138	0.0%	1,906,451	12/31/2013